title: Bevacizumab advanced melanoma (BEAM) was a positive trial.
authors.forename: David R
authors.initials: DR
authors.lastname: Minor
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*